id: MDMzMTE5MDQwMDAwODcgMjYx

reference: 03311904000087

documentId: 03311904000087

connectionPointId: 261

Stillingstittel: Postdoctoral position

Stillingsbeskrivelse:

Our research is focused on understanding the mechanisms of dynamic histone and RNA modifications in embryo development and cancer. These mechanisms, also known as epigenetic and epitranscriptomic regulation have profound effect on the development of an organism and the differentiation of normal cells to cancer cells. In particular, recent pioneering work in the field of RNA regulation and novel methodology for analysing single cells enables novel studies on valuable biological material.

Tasks:

• Knowledge of basic methods in molecular biology (cloning) and tissue culture is essential.
• Also required is experience with at least one of the following research areas: Histone modifications, RNA biochemistry methods (including PAR-CLIP, RIP-seq, and RNA-seq), RNA biology, knock-down/overexpression systems, Crispr-Cas9 based engineering and bioinformatics.
• Experience with molecular analysis of oocytes and preimplantation embryos is a particularly appreciated.

Qualifications:

Potential candidates have recently completed (or are close to completing) a PhD degree in molecular biology or medicine, with one or several publications in internationally well-regarded, peer-reviewed scientific journals. Applicants with publications in press are also considered. Interested persons should submit the following documents:

1. A concise application letter explaining your motivation for this position (1-2 pages).
2. Curriculum vitae including a list of peer-reviewed publications.
3. Contact information of three relevant References.

Personal qualities:

We are looking for an enthusiastic and determined candidate who can work both independently as well as in a group setting. The successful candidate is capable of conceptual thinking, is looking forward to learning new techniques, has good communication skills and is well organized.

We offer:

• We offer superb facilities for state-of-the-art analysis of signal cells and oocytes in an international environment.
• The position will commence as soon as possible and will extend over 3 years with an evaluation period of 3 months. A selection committee will announce the candidate two weeks after the closing deadline for interviews.
• Oslo University Hospital is an equal opportunity employer.
• The position is sponsored by The Norwegian Health Authority South-east.

Kontaktinformasjon

Helene Wold Ranum, Executive Officer, 23074062
Arne Klungland, Professor/Head of Section, 47840305

Arbeidssted

Sognsvannsveien 20
0372 Oslo

Søk på stillingen:Klikk her

Nøkkelinformasjon:

Arbeidsgiver:Oslo universitetssykehus HF

Referansenr.:4058117234
Stillingsprosent: 100%
Søknadsfrist: 19/04/2019

PAM

numberOfPosts: 1

jobCategoriesCodes_0: http://data.europa.eu/esco/isco/C2131

abstractJV_contact_0: See jobabstractJV_description

contractTypeCodes_0: fulltime

Arbeidsgiver Navn: OSLO UNIVERSITETSSYKEHUS HF

source: NAV